摘要
Liver cancer is a leading cause of cancer-related death worldwide,and its complexity and heterogeneity pose considerable challenges to conventional treatment.In recent years,the rise of organoid technology has provided new perspectives and tools for precision medicine in oncology.The use of high-fidelity organoids capable of recapitulating patients'genotypic and phenotypic features can further facilitate personalised treatment.In this review,we discuss 1)the advantages of liver cancer organoids as disease models over traditional models;2)the origin and establishment of liver cancer organoids;3)the application of liver cancer organoids technology in tumour precision medicine;4)the technical tools of liver cancer-derived organoids;and 5)current solutions for the deficiencies and challenges of liver cancer organoids.This review should provide both a deeper under-standing of the research progress and application prospects of liver cancer organoids,as well as theoretical support and practical guidance for more complete integration of liver cancer research and precision medicine.
出处
《iLIVER》
2025年第3期135-151,共17页
国际肝胆健康(英文)
基金
supported by the Shenzhen Fundamental Research Program(JCYJ20240813112004006)
the Shenzhen Health Talent Program(2022)
the Shenzhen Municipal Science and Technology Foundation(JCYJ20240813141046059)
the GuangDong Basic and Applied Basic Research Foundation(2023A1515110688,2024A1515220011)
the Guangdong Medical Science and Technology Research Fund(A2024025).
